Richard Riedel

Title: Richard Riedel: Innovator in Pharmaceutical Compositions

Introduction

Richard Riedel is a notable inventor based in Constance, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on N-acylanilinobutyric acids. With a total of 3 patents, Riedel's inventions have opened new avenues for medical treatments.

Latest Patents

Riedel's latest patents focus on compositions of and new uses for N-acylanilinobutyric acids. These pharmaceutically acceptable compositions contain at least one N-acylanilinobutyric acid as an active ingredient. The uses of these compositions extend beyond the choleretic activity suggested in U.S. Pat. No. 3,780,095. Notably, they involve the administration of smaller doses than would typically be required to achieve a choleretic effect. The new applications include increasing gastrointestinal enzyme secretion and tonicizing the cardiovascular system. The enhancement of gastrointestinal enzyme secretion is beneficial in treating various diseases, including sprue, indigestion, acute and chronic pancreatitis, and stomach ulcers. Additionally, the tonicizing of the cardiovascular system aids in increasing blood circulation in internal organs and improving liver function.

Career Highlights

Richard Riedel is associated with Byk Gulden Lomberg Chemische Fabrik GmbH, where he has been instrumental in advancing pharmaceutical research. His work has significantly impacted the development of new therapeutic approaches.

Collaborations

Riedel collaborates with Wolfgang Schoetensack, contributing to the innovative environment at their company. Their partnership has fostered advancements in pharmaceutical compositions.

Conclusion

Richard Riedel's contributions to the field of pharmaceuticals through his patents on N-acylanilinobutyric acids demonstrate his commitment to innovation and improving medical treatments. His work continues to influence the industry positively.